- Home
- CRL
CRL
Charles River Laboratories International Inc.
as 11-22-2024 4:00pm EST
| Founded: | 1947 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $212.09 | AVG Volume (30 days): | 851.5K |
| Analyst Decision: | Hold | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 8.00 | EPS Growth: | -13.25 |
| 52 Week Low/High: | $176.48 - $275.00 | Next Earning Date: | 11-06-2024 |
| Revenue: | $4,060,916,000 | Revenue Growth: | -3.67% |
| Revenue Growth (this year): | -1.61% | Revenue Growth (next year): | 1.21% |
Stock Insider Trading Activity of Charles River Laboratories International Inc. (CRL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WALLMAN RICHARD F | CRL | Director | Nov 6 '24 | Sell | $216.25 | 7,621 | $1,647,418.25 | 15,636 |
Latest Charles River Laboratories International Inc. News
CRL Breaking Stock News: Dive into CRL Ticker-Specific Updates for Smart Investing
Argus Research
9 days ago
Market Digest: APA, CBRL, CRL, DUK, SWKS, WWW, HUBS
Argus Research
9 days ago
Analyst Report: Charles River Laboratories Int
MT Newswires
11 days ago
Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing
MT Newswires
12 days ago
TD Cowen Adjusts Price Target on Charles River Laboratories International to $227 From $203, Maintains Hold Rating
Zacks
12 days ago
Charles River (CRL) International Revenue in Focus: Trends and Expectations
Business Wire
12 days ago
Charles River Laboratories to Present at UBS and Jefferies Conferences
MT Newswires
15 days ago
Barrington Adjusts Price Target on Charles River Laboratories International to $212 From $194, Maintains Outperform Rating
Simply Wall St.
15 days ago
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Compare CRL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRL Charles River Laboratories International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.